Two years after forming a strategic collaboration AMRI and PerkinElmer are helping to eliminate research and clinical data silos and advance precision medicine.
How to improve the odds of developing successful new drugs using Big Data and state-of-the-art analytical tools.
Monash Institute of Pharmaceutical Sciences is working to develop an inhaled oxytocin treatment for PPH, excessive bleeding after childbirth that kills an estimated 140,000 women a year.
The European ScreeningPort (ESP) enables academic researchers with promising data on the causes of disease to get physiologically relevant results and help support translating them into potential new therapeutics.
Developing the E-Notebook BioAssay module with sample tracking and management capabilities for a collaborative biologics environment.